The modulation of nicotine at different concentrations on γ oscillations and NMDA receptor function suggests that nAChR activation may be useful for the therapeutic application in schizophrenia, as the abnormal γ synchrony was demonstrated in the human50, 51, 52 and in the animal models29, 30, 53. Here, CHRNA4 is linked to schizophrenia.